We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$95.4B
1-Year Est. Return
38.74%
This Fund
S&P 500
This Quarter
Est. Return
+2.31%
1 Year Est. Return
+38.74%
3 Year Est. Return
+101.74%
5 Year Est. Return
+133.96%
10 Year Est. Return
+604.63%
AUM
$93.9B
AUM Growth
+$6.07B
(+6.9%)
Cap. Flow
-$705M
Cap. Flow
% of AUM
-0.75%
Top 10 Holdings %
Top 10 Hldgs %
10.12%
Holding
2,724
New
225
Increased
1,153
Reduced
856
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fluor
FLR
|
+$224M |
| 2 |
Entergy
ETR
|
+$194M |
| 3 |
General Dynamics
GD
|
+$190M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$147M |
| 5 |
Alibaba
BABA
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$291M |
| 2 |
Valero Energy
VLO
|
+$197M |
| 3 |
Wells Fargo
WFC
|
+$196M |
| 4 |
Apple
AAPL
|
+$193M |
| 5 |
Macy's
M
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.35% |
| 2 | Financials | 10.69% |
| 3 | Healthcare | 9.92% |
| 4 | Industrials | 6.49% |
| 5 | Consumer Discretionary | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Sumitomo Mitsui Financial
SMFG
$160B
| $621K | ﹤0.01% |
108,559
| – | – |
|
2102
Energy Recovery
ERII
$459M
| $619K | ﹤0.01% |
+69,656
| New | +$743K |
|
|
VCO
2103
DELISTED
Vina Concha Y Toro 50 Shrs
VCO
| $619K | ﹤0.01% |
19,457
| – | – |
|
2104
MidCap Financial Investment
MFIC
$801M
| $616K | ﹤0.01% |
37,031
+1,036
| +3% | +$17.4K |
|
2105
ResMed
RMD
$31.2B
| $616K | ﹤0.01% |
9,744
+4,300
| +79% | +$253K |
|
|
SNP
2106
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $612K | ﹤0.01% |
+8,500
| New | +$581K |
|
2107
iShares Russell 1000 Value ETF
IWD
$82.6B
| $609K | ﹤0.01% |
5,895
+2,001
| +51% | +$202K |
|
|
PAMT
2108
PAMT Corp
PAMT
$349M
| $608K | ﹤0.01% |
153,056
-9,284
| -6% | -$50.1K |
|
|
CERN
2109
CALL
DELISTED
Cerner Corp
CERN
| $604K | ﹤0.01% |
10,300
+4,700
| +84% | +$262K |
|
2110
RenaissanceRe
RNR
$13.4B
| $599K | ﹤0.01% |
5,100
-8,857
| -63% | -$1.02M |
|
2111
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.46B
| $598K | ﹤0.01% |
+19,200
| New | +$635K |
|
2112
UGI
UGI
$7.78B
| $596K | ﹤0.01% |
13,177
+1,821
| +16% | +$76.7K |
|
|
NBL
2113
PUT
DELISTED
Noble Energy, Inc.
NBL
| $595K | ﹤0.01% |
16,600
+3,400
| +26% | +$119K |
|
2114
Abercrombie & Fitch
ANF
$4.84B
| $593K | ﹤0.01% |
+33,313
| New | +$794K |
|
|
POLY
2115
DELISTED
Plantronics, Inc.
POLY
| $592K | ﹤0.01% |
+13,440
| New | +$560K |
|
2116
LivePerson
LPSN
$22.1M
| $590K | ﹤0.01% |
6,200
| – | – |
|
2117
CALL
Perrigo
PRGO
$1.48B
| $589K | ﹤0.01% |
6,500
-4,500
| -41% | -$466K |
|
2118
Stoneridge
SRI
$210M
| $589K | ﹤0.01% |
+39,401
| New | +$595K |
|
2119
Blackstone
BX
$108B
| $587K | ﹤0.01% |
23,916
-411,563
| -95% | -$10.9M |
|
2120
TransAlta
TAC
$3.9B
| $587K | ﹤0.01% |
+113,367
| New | +$574K |
|
2121
United Bankshares
UBSI
$6.7B
| $584K | ﹤0.01% |
15,562
| – | – |
|
2122
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $574K | ﹤0.01% |
+5,079
| New | +$562K |
|
|
ANTH
2123
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $569K | ﹤0.01% |
23,027
+3,575
| +18% | +$101K |
|
2124
CALL
Cencora
COR
$60B
| $563K | ﹤0.01% |
7,100
-4,100
| -37% | -$329K |
|
2125
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $563K | ﹤0.01% |
20,970
+6,784
| +48% | +$180K |
|
Similar funds
Allianz Asset Management's Q2 2016 Portfolio in Review
As of Q2 2016, Allianz Asset Management held 2,724 positions worth $93.9B, up 6.9% from $87.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Allianz Asset Management's Q2 2016 filing shows 225 new, 1,153 increased, 856 reduced and 182 closed positions. Its largest new stake was S&P Global: 874,259 shares worth $93.8M. The largest sale was Teva Pharmaceuticals, an estimated $291M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
- Allianz Asset Management's largest Q2 2016 buy was S&P Global: 874,259 shares worth $93.8M.
- Allianz Asset Management added most to Fluor in Q2 2016, an estimated $224M increase.
- Allianz Asset Management's biggest Q2 2016 reduction was Teva Pharmaceuticals, cutting an estimated $291M.
- Allianz Asset Management fully exited ATMEL CORP in Q2 2016, selling an estimated $79.4M.
- Allianz Asset Management's ten largest holdings make up 10% of its $93.9B portfolio in Q2 2016.
- Allianz Asset Management opened 225 new positions and closed 182 in Q2 2016.
- Allianz Asset Management's portfolio value rose 6.9% quarter-over-quarter to $93.9B.
Based on Allianz Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.